Radiochemical synthesis of [18F]fluororaclopride.
The radiochemical synthesis of [18F]Fluororaclopride (S-3,5-dichloro-6-methoxy-N-(1-(2-[18F]fluoroethyl)-2-pyrrolidinylmet hyl) salicylamide) is accomplished via a two step synthesis. [18F]Fluoroethyltriflate is prepared by [18F]fluoride displacement on the bis triflate of ethylene glycol. [18F]Fluoroethyl triflate is then allowed to alkylate a secondary amine precursor to yield [18F]fluororaclopride. Purification of the radiopharmaceutical involves use of a short silica BONDELUT column and subsequent reverse-phase HPLC. The final product is obtained with a radiochemical yield of approximately 15% (corrected for decay) in a synthesis time of approximately 50 min. Fluororaclopride displays a 3- to 4-fold lower affinity for the D2 receptor than does raclopride.
Kiesewetter
D O
DO
Department of Nuclear Medicine, Warren Grant Magnuson Clinical Center, National Institute of Mental Health, Bethesda, MD 20892.
Brücke
T
T
Finn
R D
RD
D005462:Fluorine Radioisotopes; D007553:Isotope Labeling / Q000379:methods*; D011954:Receptors, Dopamine / Q000378:metabolism; D017448:Receptors, Dopamine D2; D012457:Salicylamides / Q000138:chemical synthesis*; D014055:Tomography, Emission-Computed
D005462:Fluorine Radioisotopes; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D012457:Salicylamides; C061342:fluororaclopride